Revvity's (RVTY) latest next-generation suite is likely to enhance research productivity and innovation.
WALTHAM, Mass., March 20, 2024--Today, Revvity, Inc. (NYSE: RVTY) announced that it has filed a complaint against Cloud Software Group (CSG) in Massachusetts Superior Court and requested injunctive relief to enforce Revvity’s rights and CSG’s obligations as a strategic partner.
Revvity's (RVTY) next-generation newborn sequencing research workflow is likely to build the foundation for diagnosing rare diseases in the future.